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Abstract. The statistical evidence of the study here shows that countries with a low average 
COVID-19 fatality rate have high expenditures in health sector and a lower exposure of 
population to air pollution, regardless a higher percentage of population aged more than 
65 years.  This study suggest that the negative impact of future pandemics driven by novel 
viral agents can be reduced with long-run policies directed to support healthcare sector 
and sustainable environment. 
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1. Introduction  
oronavirus disease 2019 (COVID-19) is an influenza caused by the 
novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2), which appeared in late 2019 (Coccia, 2020). COVID-19 
pandemic is still circulating in 2021 with variants that continue to generate 
high numbers of COVID-19 related infected individuals and deaths in 
manifold countries worldwide (Johns Hopkins Center for System Science & 
Engineering, 2021; CDC, 2021). Seligman et al. (2021) show some 
characteristics of people that are significantly associated with COVID-19 
mortality, such as: " mean age 71.6 years, 45.9% female, and 45.1% non-
Hispanic white ... disproportionate deaths occurred among individuals with 
nonwhite race/ethnicity (54.8% of deaths … p < 0.001), individuals with 
income below the median (67.5% . . . p < 0.001), individuals with less than a 
high school level of education (25.6% … p < 0.001), and veterans (19.5% … p 
< 0.001)". In this context, the fundamental question is which economic and 
environmental factors of countries can reduce mortality of COVID-19 and as 
a consequence reduce the negative impact of COVID-19 pandemic crisis in 
society (cf., Anser et al., 2020). The study here confronts this question by 
developing a global analysis based on more than 160 countries to explain, 
whenever possible, the factors determining a lower rate of COVID-19 
mortality between countries worldwide. In particular, the main goal of this 
study is to clarify health, economic and environmental factors that have 
reduced fatality rate of the COVID-19 in society. The development of this 
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study flows from a recognition that current literature does not clarify the 
complex economic, social and institutional factors that can mitigate the 
mortality of COVID-19 between countries. The assumptions of this study are 
that wealth of nations, healthcare spending and air pollution are factors 
associated with fatality rate of COVID-19 between countries. Lessons 
learned from this study can support effective and proactive strategies for 
reducing fatality rates of infectious diseases in the presence of future 
epidemics similar to the COVID-19. This study is part of a large research 
project that investigates factors determining the transmission dynamics of 
the COVID-19 pandemic and socioeconomic effects of the COVID-19 
pandemic crisis in society to cope with future epidemics with appropriate 
policy responses (cf., Coccia, 2020, 2021).   
 
2. Theoretical framework 
Manifold studies focus on different aspects of COVID-19 pandemic crisis 
(cf., Hu et al., 2021; Tian et al., 2021). Asirvatham et al. (2020) estimate an 
adjusted case fatality rate of COVID-19 in India considering some factors of 
urban environment and population. Results suggest that urban population 
and population aged more than 60 years were associated with increased 
adjusted case fatality rate. In this context, healthcare interventions directed 
to test elderly, people with comorbidities (e.g., having diabetes, 
cardiovascular diseases, cancer, etc.) and urban population are critical public 
policies to constrain negative effects of COVID-19 pandemic in society. 
Siddiqui et al. (2020) also analyze the impact of COVID-19 pandemic in India 
and show that: “low public health expenditure combined with a lack of 
infrastructure and low fiscal response implies several challenges to scale up 
the COVID-19 response and management. Therefore, an emergency 
preparedness and response plan is essential to integrate into the health 
system of India”. Ahmed et al. (2020) focus on demographic, socioeconomic, 
and lifestyle health factors of countries to explain different COVID-19 effects 
in society. Ahmed et al. (2020) suggest that health expenditure per capita has 
a positive relation with case recovery; in addition, countries with high 
average age of population and high percentage of urban population have 
also a high fatality of COVID-19 pandemic in society. In this research field, 
Kavitha & Madhavaprasad (2020) maintain that preventive health care 
measures and policies of social distancing applied on a vast portion of 
population can constraint the spread of COVID-19. Iyanda et al. (2020) argue 
that reinforcing public health sector and epidemiological surveillance 
programs can both reduce the spread of COVID-19 and prevent unnecessary 
deaths of this infectious disease. The role of health expenditure is also 
investigated by Gaffney et al. (2020, p. 396) that maintain how: “the United 
States’ underfunded public health infrastructure, fragmented medical care 
system, and inadequate social protections impose particular impediments to 
mitigating and managing the outbreak . . . . While the United States has a 
relatively generous supply of Intensive Care Unit beds and most other health 
care infrastructure, such medical resources are often unevenly distributed or 
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deployed, leaving some areas ill-prepared for a severe respiratory 
epidemic”. González-Bustamante (2021) shows that in South America the 
social pressure on healthcare system affects interventions of governments to 
constrain the diffusion of COVID-19. In China, Jin & Qian (2020) analyze: 
“the Chinese public-health expenditure at national and provincial levels …, 
and then compare it with the expenditures of other countries. The results 
show that: (1) the level of public-health expenditure in China is relatively 
low and far lower than that in developed countries; (2) Chinese governments 
have not paid enough attention to the prevention and control of major 
public-health emergencies, which may be an important reason for the 
outbreak of COVID-19; (3) Chinese public-health expenditure shows a 
fluctuating growth trend, but the growth rate is so slow that it is lower than 
that of GDP and fiscal expenditure; (4) although the Chinese government 
inclines the public-health expenditure to the poor provinces in central and 
western regions, the imbalance and inequity of public-health resource 
allocation are still expanding among provinces; (5) there is a lot of waste of 
resources in the public-health system, which seriously reduces the efficiency 
of public-health expenditure in China. Therefore, the Chinese government 
should improve the quantity and quality of public-health expenditure in the 
above aspects”. Kapitsinis (2020) investigates the diffusion of the novel 
coronavirus in nine European countries and pinpoints that health 
investments play a vital role to alleviate mortality rate of the COVID-19. 
Instead, Barrera-Algarín et al. (2020) show that in Europe, a lower level of 
government health investments per capita is associated with high numbers 
of COVID-19 deaths per million inhabitants; in general, a high mortality of 
COVID-19 is also due to low health expenditure associated with high income 
inequality. Finally, Perone (2021) analyzes Italy and shows that health care 
efficiency is one of the factors associated with the reduction of fatality rate; 
moreover, population aged 70 years and above, and concentration of air 
pollutants are positively associated with fatality rate in society.  
Overall, then, current literature shows that economic system and 
interventions of public policy in specific countries (e.g., India, China, the 
USA, Italy, etc.) have generated different effects of the evolution of COVID-
19 pandemic in society. However, what is hardly known is to explain and 
generalize at global level which economic and environment factors of 
countries can lower mortality of COVID-19 in society to design effective and 
proactive strategy to constrain future epidemics similar to COVID-19.  
 
3. Materials and methods 
This study has the primary objective to explain factors determining a 
lower fatality rate of the COVID-19 between countries. Results can explain 
and generalize, whenever possible, vital characteristics of countries for 
designing an effective and proactive strategy to limit negative impact of 
future COVID-19 pandemic crisis and similar epidemics. 
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3.1. Sample and working hypothesis 
The study is based on a sample of 161 countries that is categorized in two 
sub-samples according to the level of Gross Domestic Product (GDP) per 
capita (wealth of individuals) of nations is higher/lower than arithmetic 
mean of the sample N=161, to compare groups having similar socioeconomic 
framework.  
The main working hypothesis of this study is that high GDP per capita 
and healthcare spending, and low air pollution are factors associated with 
reduction of the fatality rate of COVID-19 between countries.  
 
3.2. Measures 
The measures for statistical analyses are:  
 Number of COVID-19 infected individuals (%) is measured with 
confirmed cases of COVID-19 on 14 December 2020 divided by population 
of countries under study. Source of data: Johns Hopkins Center for System 
Science and Engineering (2021). 
 Number of COVID-19 deaths is measured with fatality rate (%) of 
COVID-19 given by deaths on 14 December 2020 divided by total infected 
individuals in countries. Source of data: Johns Hopkins Center for System 
Science and Engineering (2021). 
 Wealth of population is measured with Gross Domestic Product (GDP) 
per capita, Purchasing Power Parity (PPP-current international U.S. dollars 
$) in 2019 (last year available in dataset). GDP per capita is gross domestic 
product divided by midyear population. GDP is the sum of gross value 
added by all resident producers in the economy plus any product taxes and 
minus any subsidies not included in the value of products. It is calculated 
without making deductions for depreciation of fabricated assets or for 
depletion and degradation of natural resources. Source of data: World Bank 
(2020).  
 The expenditures in health sector are measured by:  
a) Level of current health expenditure expressed as a percentage of GDP 
in 2017 (last year available in dataset). Estimates of current health 
expenditures include healthcare goods and services consumed during each 
year. Although this indicator does not include capital health expenditures 
(e.g., buildings, machinery, IT and stocks of vaccines for emergency or 
outbreaks), it is a main proxy of investments in health sector; in fact, 
countries having higher levels of health expenditures as percentage of GDP 
also tend to have a higher level of Research and Development expenditure 
(% of GDP)1 : bivariate correlation, using data of 2017, shows a positive 
coefficient equal to r=.45 (p-value 0.01, N=115 countries), whereas regression 
analysis with log-log model reveals that a 1% increase in the Research and 
Development expenditure (% of GDP), it increases expected current health 
 
1 Gross domestic expenditures on research and development (R&D), expressed as a percent 
of GDP, include both capital and current expenditures in the four main sectors: business 
enterprise, government, higher education and private non-profit. R&D covers basic 
research, applied research, and experimental development. 
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expenditure (% of GDP) of .14% (p-value .001; coefficient R2 indicates that 
about 20% of the variation of health expenditure can be attributed linearly to 
Research and Development expenditure; cf., Coccia, 2012, 2018). Source of 
data: World Bank (2020a);  
b) Domestic general government health expenditure per capita, PPP 
(current international $) in 2017 (last year available): Public expenditure on 
health from domestic sources per capita expressed in international dollars at 
purchasing power parity (PPP time series based on ICP2011 PPP). Source of 
these data is also World Bank (2020b). 
 Elderly are measured with population aged 65 years and above as a 
percentage of the total population (population here counts all residents 
regardless of legal status or citizenship in 2019, last year available). Source: 
World Bank (2020c). Population aged 65 and above is an important factor in 
infectious diseases because many studies show negative effects of COVID-
19 on health of old people (Cohen-Mansfield, 2020; Perone, 2021).   
 Air pollution in environment is measured by percent of population 
exposed to ambient concentrations of PM2.5 that exceed the World Health 
Organization (WHO) guideline value in 2017 (last year available). In 
particular, it indicates the portion of a country’s population living in places 
where mean annual concentrations of PM2.5 are greater than 10 micrograms 
per cubic meter, the guideline value recommended by the WHO as the lower 
end of the range of concentrations over which adverse health effects due to 
PM2.5 exposure have been observed. Source: World Bank (2020d). In this 
context, studies reveal that areas with frequently high levels of air pollution 
— exceeding safe levels of ozone or particulate matter — had higher 
numbers of COVID-19 related infected individuals and deaths (Coccia, 2020, 
2021, 2021a; Martelletti & Martelletti, 2020). Moreover, high concentrations 
of particulate air pollutant induce serious damages to the immune system of 
people, weakening human body to cope with infectious diseases of (new) 
viral agents and other diseases (Glencross et al., 2020).   
 Containment measures against the spread of COVID-19 are assessed 
with total days of lockdown across countries in the year 2020 (Coccia, 2021b). 
Tobías (2020, p. 2) states that: “Lockdown, including restricted social contact 
and keeping open only those businesses essential to the country's supply 
chains, has had a beneficial effect”. Flaxman et al. (2020) show that 
lockdowns seem to have effectively reduced transmission of the COVID-19. 
Atalan (2020) argues that countries can start lockdown when there is an 
acceleration of daily confirmed cases beyond a critical threshold and can end 
it when there is a strong reduction of Intensive Care Unit (ICU) admissions 
(cf., Chaudhry et al., 2020). Source: COVID-19 pandemic lockdowns (2021). 
 
3.3. Data analysis procedure 
The sample of N=161 countries is divided in two sub-samples (group 1 and 
2) having similar socioeconomic conditions for a comparative analysis as 
follow:  
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 group 1: countries with a Gross Domestic Product per capita higher than 
arithmetic mean of the sample 
 group 2: countries with a Gross Domestic Product per capita lower and/or 
equal than arithmetic mean of the sample 
Firstly, data are analyzed with descriptive statistics of variables given by 
arithmetic mean (M) and standard deviation (SD), doing a comparative 
analysis between two groups of countries just mentioned. In addition, the 
normality of the distribution of variables, to apply correctly parametric 
analyses, is analyzed with skewness and kurtosis coefficients; in the presence 
of not normal distributions, variables are transformed in logarithmic scale to 
have normality.  
Secondly, follow-up investigation is the Independent Samples t-Test that 
compares the means of two independent groups in order to determine 
whether there is statistical evidence that the associated population means are 
significantly different. The assumption of homogeneity of variance in the 
Independent Samples t Test -- i.e., both groups have the same variance --  is 
verified with Levene's Test based on following hypotheses:  
 
H0: σ12 - σ22 = 0 (population variances of group 1 and 2 are equal) 
H1: σ12 - σ22 ≠ 0 (population variances of group 1 and 2 are not equal) 
 
The rejection of the null hypothesis in Levene's Test suggests that 
variances of the two groups are not equal: i.e., the assumption of 
homogeneity of variances is violated. If Levene’s test indicates that the 
variances are equal between the two groups (i.e., p-value large), equal 
variances are assumed. If Levene’s test indicates that the variances are not 
equal between the two groups (i.e., p-value small), the assumption is that 
equal variances are not assumed. 
After that, null hypothesis (H’0) and alternative hypothesis (H’1) of the 
Independent Samples t-Test are: 
 
H’0: µ1 = µ2, the two population means are equal in countries with a higher 
and lower level of GDP per capita 
H’1: µ1 ≠ µ2, the two population means are not equal in countries having a 
higher and lower level GDP per capita 
Statistical analyses are performed with the Statistics Software SPSS 
version 26.  
 
4. Results 
The arithmetic mean (M) of the GDP per capita in 2019 of the sample 
(N=155 valid countries and 6 missing values) is M=$22,794; as consequence 
the two groups for a comparative analysis are: 
 Countries with a Gross Domestic Product per capita in 2019 > $22,794, N= 
58 countries 
 Countries with a Gross Domestic Product per capita in 2019  $22,794, N=98 
countries 
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Table 1. Descriptive statistics  
 
Countries with a Gross Domestic 
Product per capita  
in 2019   $22,794 
Countries with a Gross Domestic 
Product per capita  
in 2019 > $22,794 
Description of variables M SD M SD 
­ Cases/population, % 2020 0.81 1.11 2.39 1.66 
­ Fatality rate, % 2020 2.28 1.57 1.68 0.88 
­ GDP per capita PPP ($), 2019 $8,538.85 $6,035.58$ 4$46,634.61 $20,215.07 
­ Health expenditure (% of GDP), 2017 5.97 2.12 7.59 2.77 
­ General government health expenditure per capita, PPP 
($), 2017 $243.72 $260.29 $2,323.90 $1,373.42 
­ Population aged 65 years and above as a percentage of 
population, 2019 5.83 3.85 15.07 6.41 
­ PM2.5 air pollution, population exposed to levels 
exceeding WHO guideline value (% of total), 2017 97.70 11.95 72.34 38.23 
­ COVID-19 pandemic lockdowns (days), 2020 55.26 51.22 96.71 85.79 
Note: M= arithmetic mean; SD= Standard Deviation.  
 
 
Figure 1. Fatality of COVID-19, health expenditure and population exposed to high levels of air 
pollution in countries with GDP per capita higher/lower than $22,794. Note: log scale of PM2.5 
air pollution is to have comparable numbers in the bar graph 
 
Table 1 shows that fatality rate is lower in richer countries (1.68%) that 
have an average GDP per capita more than $46,600, a high level of health 
expenditure of roughly 7.6% of GDP, a high level of government health 
expenditure of about $2,300 per capita, a lower exposure of population to 
levels exceeding PM2.5 air pollution according to WHO guidelines, and 
finally a longer period of lockdown, regardless a higher percentage of 
population aged 65 years and above and a higher incidence of confirmed 
cases on population in these countries (cf., Figure 1).   
Table 2 shows the Independent Samples t Test, as follow-up inspection, 
to assess the significance of the difference of arithmetic mean between 
groups of countries under study. The p-value of Levene's test is significant, 
and we have to reject the null HP of Levene's test and conclude that the 
variance in the groups under study is significantly different (i.e., equal 
variances are not assumed), except lockdown (days) that has p-value<.06 
and equal variances are assumed. Table 2 reveals a statistically significant 
difference of arithmetic mean between groups having GDP per capita 
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lower than $22,794 (group 1) and higher than $22,794 (group 2) as indicated 
in table 1.  
In particular, table 2 substantiates that: 
 There was a significant difference in average cases/population % 
between groups 1 and 2 (t88.15 = 6.43, p < .001) 
 There was a significant difference in average fatality rate % between 
groups 1 and 2 (t153.67 = 3.06, p < .01) 
 There was a significant difference in average GDP per capita between 
groups 1 and 2 (t63.13 = 13.98, p < .001) 
 There was a significant difference in average health expenditure (% 
of GDP) between groups 1 and 2 (t96.66 = 3.86, p < .001) 
 There was a significant difference in average government health 
expenditure per capita between groups 1 and 2 (t59.48 = 11.41, p < .001) 
 There was a significant difference in average population aged 65 
years and above as a percentage of total population between groups 1 and 2 
(t81.80 = 9.98, p < .001) 
 There was a significant difference in average population exposed to 
levels of PM2.5 air pollution exceeding WHO guideline value (% of total) 
between groups 1 and 2 (t52.34 = 3.19, p < .01) 
 There was a significant difference in average days of COVID-19 
pandemic lockdowns between groups 1 and 2 (t70.00 = 2.03, p < .05) 
 
Table 2. Independent Samples Test 
  
Levene’s Test 
for equality of 
variances t-test for equality of Means 








2020 Equal variances assumed 17.462 0.001 -7.079 153.000 0.001 -0.016 0.002 
 Equal variances not assumed   -6.431 88.151 0.001 -0.016 0.002 
Fatality rate %,  
2020 Equal variances assumed 7.842 0.006 2.671 154.000 0.008 0.006 0.002 
 Equal variances not assumed   3.057 153.670 0.003 0.006 0.002 
GDP per capita PPP 
($), 2019 Equal variances assumed 46.016 0.001 -17.345 153.000 0.000 -38095.761 2196.380 
 Equal variances not assumed   -13.984 63.132 0.001 -38095.761 2724.193 
Health expenditure 
(% of GDP), 2017 Equal variances assumed 4.929 0.028 -4.127 154.000 0.001 -1.627 0.394 
 Equal variances not assumed   -3.859 96.660 0.001 -1.627 0.422 
General government 
health expenditure 
per capita, PPP ($), 
2017 Equal variances assumed 163.442 0.001 -14.446 152.000 0.001 -2080.181 143.998 
 Equal variances not assumed   -11.412 59.484 0.001 -2080.181 182.286 
Population ages 65 
years and above as a 
percentage of 
population, 2019 Equal variances assumed 21.540 0.001 -11.266 154.000 0.001 -9.244 0.821 
 Equal variances not assumed   -9.975 81.803 0.001 -9.244 0.927 
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Log PM2.5 air 
pollution, population 
exposed to levels 
exceeding WHO 
guideline value (% of 
total), 2017 Equal variances assumed 59.944 0.001 4.311 148.000 0.001 0.518 0.120 
 Equal variances not assumed   3.190 52.335 0.002 0.518 0.162 
Log days COVID-19 
lockdowns, 2020 Equal variances assumed 3.749 0.057 -2.030 70.000 0.046 -0.433 0.213 
 Equal variances not assumed   -1.999 61.106 0.050 -0.433 0.217 
 
Hence, findings suggest that fatality rate in richer countries (1.7%) is 
lower than medium-low income per capita countries (2.3%). Factors 
determining the mitigation of the fatality of COVID-19 in society can be due 
to a higher level of health expenditure of roughly 7.6% of GDP, higher level 
of government health expenditure per capita of about $2,300, a lower 
exposure of population to levels exceeding PM2.5 air pollution according to 
WHO guidelines and a longer duration of lockdown, though countries with 
lower fatality rates have a higher percentage of population aged 65 years and 
above (considered as a risk group in population; cf., European Centre for 
Disease Prevention and Control, 2021)2 and a higher incidence of confirmed 
cases in population. These statistical analyses provide important, very 
important results to explain factors associated with the effects of COVID-19 
pandemic in society. In particular, an effective strategy to cope with global 
pandemic crisis has to be based on three main public policies: 
 health policy with higher levels of healthcare expenditure as 
percentage of GDP directed to specific target of efficiency of overall 
healthcare sector 
 environmental policies based on sustainability for reducing the 
exposure of population to air pollution 
 and finally, a timely policy response based on containment and 
mitigation measures  in a context of advanced economies. 
 
5. Discussion and policy implications 
Lau et al. (2021) argue that in the presence of a continuous global COVID-
19 pandemic threat, actual confirmed cases appear vague numbers and 
suggest the mortality rate as the main indicator to evaluate the real effects of 
COVID-19 in society (cf., Antony et al., 2020; Liu et al., 2021). In this context, 
one of the goals of nations to cope with COVID-19 pandemic crisis is to 
mitigate the mortality rate (cf., Coccia, 2020a). Previous studies suggest that 
measures of containment, such as full lockdown, can reduce the human-to-
human transmission dynamics of infectious diseases and negative effects of 
COVID-19 pandemic in society (Atalan, 2020; Prem et al., 2020; Tobías, 2020).  
 
2 For instance, in this context, at 9 December 2020, fatality rate in Italy as a percentage of the 
age group was 3% (between people having 60-69 years), 10.2% (70-79 years), 19% (80-89) 
and finally about 23% in population aged > 90 years (ISS, 2020; cf., Perone, 2021).  
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However, these policy responses are necessary but, of course, not 
sufficient conditions to constraint a negative impact of pandemics in society 
because many countries with a longer duration of lockdown have also a very 
high fatality rate, such as Italy; as a consequence an additional inquiry is 
needed (Coccia, 2021b). What this study adds to current studies on the COVID-
19 pandemic crisis, performing a global analysis of countries, is to explain, 
whenever possible, factors determining a lower rate of fatality between 
countries to support a comprehensive strategy to cope with future epidemics 
similar to COVID-19. In particular, this study confirms that GDP per capita, 
healthcare spending and air pollution are factors associated with fatality rate 
of COVID-19 across countries. Findings here can suggest general guidelines 
to mitigate fatality rates of future epidemics similar to COVID-19  as 
schematically summarized in the figure 2. 
 
 
Figure 2. Factors determining a mitigation of fatality rates of COVID-19 between 
countries to design general guidelines to constrain pandemic crises of novel viral agents 
similar to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that is the 
strain of the novel influenza that causes coronavirus disease 2019 (COVID-19). 
  
Hence, follow-up materials to reduce fatality rates of COVID-19 have to 
be focused on structural public policies and appropriate policy responses to 
cope with a constant pandemic threat. Especially, 
 Health Policy   
This study reveals that countries with lower fatality rates have a high level 
of health expenditure given by 7.6% of GDP and government health 
expenditure per capita of about $2,300, whereas countries with higher 
fatality rates have a health expenditure of roughly 6% of GDP and very low 
government health expenditure per capita (a mere average value of about 
$243 per inhabitants) that indicates a weak healthcare sector to cope with 
pandemics and also other diseases in society. Scholars, to reduce the risk 
factors of COVID-19 mortality, also consider socioeconomic, clinical, 
physical, biophysiological, and biochemical characteristics of people, which 
can be affected by the type of nutrition system, toxicity, and ecological 
footprint (Aljerf & Aljurf, 2020). Other scholars, such as Kapitsinis (2020), 
argue that investments in health sector are a critical public policy to mitigate 
mortality rate of COVID-19. In this context, countries should also support 
the expansion of hospital capacity and testing capabilities to reduce 
diagnostic delays of infectious diseases and foster new technology with the 
development of effective vaccines, antivirals and other innovative drugs that 
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can counteract future public health threats of new epidemics similar to 
COVID-19 (Ardito et al., 2021; Coccia, 2019, 2020). 
 Environmental policy  
This study finds that sustainable environment plays a vital role for 
reducing the impact of COVID-19 in terms of COVID-19 related infected 
individuals and deaths; in particular, a low rate of fatality is associated with 
a low level of air pollution (cf., Coccia, 2020, 2020b, 2020c). In fact, average 
population exposed to levels exceeding WHO guideline value (% of total) is 
72% in countries with a lower level of fatality rate, whereas in countries with 
a higher incidence of mortality of the COVID-19 is almost 98%! Coccia (2020, 
2021) shows that number of infected people was higher in Italian cities with 
>100 days per year exceeding limits set for PM10 or ozone. Copat et al. (2020), 
considering different studies about the relation between air pollution and the 
spread of COVID-19, suggest that PM2.5 and NO2 can support the spread and 
lethality of COVID-19, but additional analyses are needed to confirm this 
relation concerning transmission dynamics of the SARS-CoV-2 (cf., Coccia, 
2021). Coccia (2020), using a case study of Italy, explains that: “the max 
number of days that Italian provincial capitals can exceed per year the limits 
set for PM10 (particulate matter 10 µm or less in diameter) or for ozone, 
considering the meteorological conditions, is about 48 days. Beyond this 
critical point, … environmental inconsistencies, because of the combination 
between air pollution and meteorological conditions, trigger a take-off of 
viral infectivity (epidemic diffusion) with damages for health of population, 
economy and society” (cf. also Aljerf & Aljurf, 2020). In fact, days of air 
pollution, associated with climate change, affect the health of population and 
environment (Coccia, 2020; 2021). In this field of research, Carugno et al. 
(2018) analyze respiratory syncytial virus (RSV), the primary cause of acute 
lower respiratory infections in children: bronchiolitis. The study suggests 
that seasonal weather conditions and concentration of air pollutants seem to 
influence RSV-related bronchiolitis epidemics in Italian urban areas. In 
particular, airborne particulate matter (PM) may influence the children's 
immune system and foster the spread of RSV infection. This study also 
shows a correlation between short- and medium-term PM10 exposures and 
increased risk of hospitalization because of RSV bronchiolitis among infants. 
Glencross et al. (2020) discuss that air pollution in the long run can cause 
diseases by perturbing multicellular immune responses, because areas with 
high air pollution are associated with increased exacerbations of asthma and 
novel influenza viruses (Coccia, 2020, 2020a, 2021). Moreover, in outdoor 
environment, studies suggest that the concentration of atmospheric 
pollutants is associated with the spread of SARS-CoV-2 (Coccia, 2020; 
Martelletti &Martelletti, 2020), but a high wind speed sustains clean days 
from air pollution, reducing whenever possible the spread of COVID-19 and 
other infectious diseases (cf., Coccia, 2020; Rosario et al., 2020). To put it 
differently, a low wind speed in cities prevents the dispersion of air 
pollutants that can include bacteria and viruses, such as SARS-CoV-2, and 
can increase the incidence of COVID-19 in society, such as in some European 
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regions (Coccia, 2020, 2021). Instead, in external environment, high wind 
speed supports the dilution and removal of the droplets, decreasing the 
concentration of viral agents in the air and the transmission dynamics of viral 
infectivity among people (cf., Coccia, 2020b, 2020c). In fact, Rosario et al. 
(2020, p. 4) also show that wind improves the circulation of air and also 
increases the exposure of the novel coronavirus to the solar radiation effects, 
a factor having a negative correlation in the diffusion of COVID-19. Guo et 
al. (2019) argue that haze pollution is a serious environmental problem 
affecting cities, proposing policies for urban planning that improve 
respiratory health of population. In addition, scholars argue that: “besides 
some high negative externalities associated with COVID-19 pandemic in the 
form of increasing death tolls and rising healthcare costs, the global world 
should have to know how to direct high mass carbon emissions and 
population growth through acceptance of preventive measures, which 
would be helpful to contain coronavirus pandemic at a global scale” (Anser 
et al., 2020). In fact, Marazziti et al. (2021) point out that the activities of 
human society do not consider the long-term damages of climate change and 
of high air pollution that may increase in future more and more the diffusion 
of novel influenza viruses. Reilly et al. (2021) maintain that one of the main 
effects of the COVID-19 pandemic crisis on climate change can be its 
influence on national commitments to action, such as  recovery funds 
directed to low carbon investments. As a matter of fact, improvements in air 
quality have been accompanied by demonstrable benefits to human health. 
In this perspective, countries should introduce organizational, product and 
process technologies directed to a sustainable development for the 
improvement of environment, atmosphere, air quality and especially public 
health of population to cope with future epidemics similar to COVID-19 and 
other diseases that generate cardiovascular and respiratory disorders in 
society (Amoatey et al., 2020; Siafakas et al., 2018).  
 Public policy responses  
This study also shows that a lower mortality of COVID-19 is associated 
with countries having a timely application of lockdowns. The model by 
Balmford et al. (2020) reveals that countries with an immediate application 
of full lockdown reduced deaths compared to countries that delayed the 
application of this strong containment measure. Gatto et al. (2020) maintain 
that restriction to mobility and human interactions can reduce transmission 
dynamics of the COVID-19 by about 45%. In addition, Janssen & van der 
Voort (2020) show the utility of “smart lockdown” as policy responses based 
on suggested and not mandated mitigation measures that are focused on 
responsibility of individuals. In this context, new studies show that specific 
places have a high risk to be COVID-19 outbreaks (e.g., restaurants, gyms, 
stadium, discotheques, etc.; cf., Chang et al., 2020); as a consequence, selected 
measures of containment (e.g., restricting maximum occupancy of specific 
places, social distancing and wearing of face masks) can be more effective 
interventions to constrain the spread of COVID-19, without deteriorating 
economic system, than policies based on uniformly reduction of the mobility 
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of people (Chang et al., 2020; cf., Coccia, 2021b; Renardy et al., 2020). Studies 
also report that containment measures for COVID-19 pandemic crisis might 
affect mental health with: "disturbances ranging from mild negative 
emotional responses to full-blown psychiatric conditions, specifically, 
anxiety and depression, stress/trauma-related disorders, and substance 
abuse. The most vulnerable groups include elderly, children, women, people 
with pre-existing health problems especially mental illnesses, subjects taking 
some types of medication including psychotropic drugs, individuals with 
low socio-economic status, and immigrants” (Marazziti et al., 2021). Simon et 
al. (2021) confirm that: “The negative capability well-being, mental health 
and social support impacts of the Covid-19 lockdown were strongest for 
people with a history of mental health treatment. Future public health 
policies concerning lockdowns should pay special attention to improve 
social support levels in order to increase public resilience”.  
In general, a continuous pandemic threat highlights fragility, 
vulnerability and weakness of ecosystem and society, and the difficulties of 
countries to cope with unforeseen crises. Hence, pandemic threats given by 
novel infectious diseases, such as the COVID-19, in the long run need timely 
policy responses of containment based on agility and adaptive governance 
of nations supported by efficient expenditures in health sector and 
sustainable policies for reducing air pollution (cf., Coccia, 2020, 2021). In the 
short run, efficient health systems can support the management of COVID 
19 vaccinations to constrain current and future negative effects of pandemics 
in society (DeRoo et al., 2020; Frederiksen et al., 2020; Harrison & Wu, 2020). 
Evans & Bahrami (2020) pinpoint that super-flexibility can be an appropriate 
approach to cope with pandemic threats of current COVID-19 in which 
decision making of policymakers should be oriented to versatility, agility, 
and resilience. In short, this study, to reiterate, suggests that to constrain the 
negative impact in society of constant pandemic threats, nations have to 
apply public policies directed to increase expenditures in health sector and 
reduce the sources of air pollution for improving healthcare of population in 
a context of sustainable environment (Coccia, 2020; Sabat et al., 2020, p. 917). 
 
6. Conclusion observations and limitations 
This statistical analysis here suggests that GDP per capita, healthcare 
spending and air pollution are factors associated with reduction of fatality 
rate of COVID-19 between countries. In particular, this new study here finds 
that countries with a low average COVID-19 fatality rates have high 
expenditures in health sector >7.5 (% of GDP), high health expenditures per 
capita >$2,300 and a lower exposure of population to days exceeding safe 
levels of particulate matter (PM2.5). Results of the study here also suggest that 
general guidelines for a global strategy to cope with pandemic threat have 
to be based on a public policy that supports health system with effective 
expenditures and investments, and an environmental policy directed to 
sustainability that reduces the exposure of population to air pollution. These 
public policies can induce a reduction of fatality rates in the presence of 
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pandemics, regardless a higher incidence of confirmed cases and a higher 
percentage of elderly on total population. 
In addition, results here can also suggest ambidexterity strategies of crisis 
management for more prosperous or less favored countries: 
 Rich countries can focus in the short run on measures of containment 
of shorter duration because of a stronger healthcare sector based on high 
health expenditures (as % of GDP), whereas  in the long run these countries 
should  support environmental policies for reducing air pollution  
 Developing countries have to focus in the short run on measures of 
containment of a longer duration because of a weak healthcare sector based 
on low health expenditures (as % of GDP) and in the long run have to 
support  policies for enhancing health system and health of population. 
These conclusions are, of course, tentative. A main concern is that there 
can be differences among countries belonging to the same group of 
developed and developing countries, having a similar level of GDP, because 
they can have different healthcare expenditures, institutional contexts and 
apply different strategies of pandemic management. In fact, despite the 
study here provides main findings to better design policy responses to 
pandemic threat, other confounding factors that influence variables under 
study here (e.g., institutional aspects, culture, religion, political system, 
structure of pharmaceutical industry, investments in hospital sector, in 
prevention, in medical personnel, etc.) need to be considered for more 
comprehensive analysis and policy responses of countries (cf., Stribling et al., 
2020). The positive side of this study is a global analysis of more than 160 
countries to generalize, whenever possible, findings here that are prima facie 
(i.e., accepted as correct until proved otherwise) to support appropriate 
policy responses at country level. However, future studies have also to focus 
on follow-up materials and questions investigating the role of different 
organizational and financing modes of healthcare systems and the allocation 
of financial resources between healthcare activities (e.g., preventive and 
curative care) or groups of healthcare providers (for example, hospitals and 
ambulatory centers) because can affect the health system capability of 
countries to cope with current and future pandemic crises. In fact, results 
here have also to be reinforced with much more follow-up investigation 
concerning detailed research into the relations between negative effects of 
pandemic threat in society, health systems, public health capacity and 
pandemic response of countries.  
Overall, then, this study suggests that an effective strategy to reduce the 
negative impact of future pandemic threats, similar to COVID-19, in terms 
of fatality rates in society, has to be based on high expenditures (and 
investments) in health system and on policies of sustainable development to 
improve public health and overall ecosystem. To conclude, this study here 
could represent a starting point to analyze further socio-economic factors 
that may shape and support general guidelines for a global strategy to cope 
with future pandemic threats both in more prosperous and less favored 
countries.   
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